OpenAlex
PricingAboutJobs
Log inGet started
Work

Consequences of rifampicin treatment on propafenone disposition in extensive and poor metabolizers of CYP2D6

HTML

Year: 1999
Type: article
Study design: Clinical Trial
Source: Pharmacogenetics and Genomics
DOI: 10.1097/01213011-199910000-00002
Authors: Karin Dilger, Bernd Greiner, Martin F. Fromm, Ute Hofmann, Heyo K. Kroemer, Michel Eichelbaum
Institutions: Universität Greifswald, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, University of Tübingen
Language: English

Topic: Pharmacogenetics and Drug Metabolism
Subfield: Pharmacology
Field: Pharmacology, Toxicology and Pharmaceutics
Domain: Life Sciences
Keywords: propafenone, rifampicin, CYP2D6 polymorphism, drug interactions, enzyme induction, bioavailability, pharmacokinetics, QRS prolongation, antiarrhythmic drugs, N-dealkylation, 5-hydroxypropafenone, oral versus intravenous administration, tuberculosis treatment
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2042538807
FWCI: 3.059
Cites:
Cited by: 72
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security